CANTOR D798VC00001

Gastrointestinal tumors
Colorectal cancer
First-Line-Therapy (Metastatic Disease/Hematology)
The main purpose of this study is to evaluate the safety and efficacy of novel studyinterventions and combinations in participants with Colorectal Cancer (CRC).
The main purpose of this study is to evaluate the safety and efficacy of novel studyinterventions and combinations in participants with Colorectal Cancer (CRC). A Phase II, Open-Label, Multicenter, Master Protocol to Evaluate the Safety and Efficacy of Novel Study Interventions and Combinations in Participants with Colorectal Cancer (CANTOR)